The simultaneous “knockdown” of such cancer cells by silencing the expression of STAT3, which interacts independently with the transcription factor NANOG, and treatment of the cells with xanthone-derived compounds leads to the activation of mechanisms, including ROS-dependent mechanisms, leading to the elimination of the cancer cells. Here, NANOG is linked to cancer.